Polymorphisms in genes such as PNPLA3, TM6SF2, and GCKR promote steatosis through interaction with distinct metabolic mechanisms, predisposing to metabolic dysfunction-associated fatty liver disease [21]. The gene discussed is TM6SF2; the disease is steatosis.